SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-17-002229
Filing Date
2017-03-21
Accepted
2017-03-21 16:39:36
Documents
7
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v032117_10KA.htm 10-K/A 102919
2 EXHIBIT 10.18 v032117_EX1018.htm EX-10.18 37655
3 EXHIBIT 10.19 v032117_EX1019.htm EX-10.19 86192
4 EXHIBIT 31.1 tgtx_ex311.htm EX-31.1 17105
5 EXHIBIT 31.2 tgtx_ex312.htm EX-31.2 17195
6 EXHIBIT 32.1 tgtx_ex321.htm EX-32.1 5980
7 EXHIBIT 32.2 tgtx_ex322.htm EX-32.2 5931
  Complete submission text file 0001654954-17-002229.txt   274271
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32639 | Film No.: 17704593
SIC: 2834 Pharmaceutical Preparations